In April, Mr. Miquelon projected Walgreen’s pharmacy-unit earnings, before interest and taxes, would be $8.5 billion for fiscal year 2016, which was based partly on contracts to sell drugs under Medicare. However, in July, he decreased his forecast due to a $1.1 billion forecasting error for the company’s Medicare-related business.
In his lawsuit, Mr. Miquelon alleges there was a defamatory article published by the Wall Street Journal in August, which reported he and President of Pharmacy, Health and Wellness Kermit Crawford were stepping down following the forecasting error, which made it appear Mr. Miquelon was the party responsible for the mistake. The lawsuit also referenced an “even more defamatory” article that was published on Sept. 30, according to the report.
Although the articles made it appear Mr. Miquelon was responsible for the forecasting error and was forced to step down, he claims he decided to pursue other career opportunities and leaving Walgreen was a personal choice.
In his lawsuit, Mr. Miquelon also claims Walgreen CEO Gregory Wasson and Stefano Pessina, the company’s largest shareholder, defamed him by making false comments about him to investors, according to the report.
Mr. Miquelon claims the allegedly defamatory reports and comments have negatively affected his career opportunities.
More articles on healthcare industry lawsuits:
7 latest healthcare industry lawsuits, settlements
Sampling, extrapolation to prove FCA liability approved by district court
65 False Claims Act cases unsealed since June: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
